Faber Logo Skip to main content

Maria Stracqualursi


Maria counsels technology and life sciences companies from their formation through merger or acquisition.

She represents early-stage companies in venture capital and other financing transactions, and also assists them with a variety of corporate law matters, including employment, equity compensation, consulting, confidentiality, restructuring and corporate governance matters. Maria also has experience representing private companies in domestic and cross-border mergers and acquisitions.

More about Maria

Corporate Associate

Rich May, P.C.
  • Advised clients in equity and debt finance transactions
  • Counseled startups with respect to formation, stock incentive plans and corporate governance
  • Represented companies in mergers and acquisitions

Corporate Associate

Orrick, Herrington & Sutcliffe
  • Represented technology companies in formation, financings, acquisitions, sales and other corporate transactions

  • Preferred equity financing of PIC Therapeutics by Orbimed, Advent and others
  • Preferred equity financing of Summation Bio by Droia, RA Capital and others
  • Preferred equity financing of Vizgen by Arch Ventures, Northpond Ventures, Sofina Partners, Blue Water and others
  • Preferred equity financing of Dianthus Therapeutics by 5AM Ventures, Fidelity Management & Research Company, Venrock Healthcare Capital Partners, Fairmount Funds, Avidity Partners, Wedbush Healthcare Partners, Tellus BioVentures and others
  • Preferred equity financing of NextPoint Therapeutics, Inc. by Bayer, Sanofi, Catalio, MPM and others
  • Palette Life Sciences acquisition by Teleflex Incorporated

Maria has assisted pro bono clients with name-change and asylum matters. She is proficient in Spanish.

Interested in working with Maria?

Our team is eager to learn more about your project

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.